Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancerWei Wei, Jibin Li, Xiaqin Cheng et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 38
Development and External Validation of a Novel Model for Predicting Postsurgical Recurrence and Overall Survival After Cytoreductive R0 Resection of Epithelial Ovarian CancerQiaqia Li, Jundong Li, Yinghong Deng et al.|Frontiers in Oncology|2022Cited by 4